Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 20 Biotechnology Startup Investors in Hungary

Last updated: Apr 2024 A list of 20 angel investors and VC funds that invest in Biotechnology startups based in Hungary. We rank investors based on the number of investments they made in Biotechnology companies from Hungary. We update this investor list every month.

Top 20 Biotechnology Startup Investors in Hungary

Investor	Biotechnology Hungary investments
FastVentures	4
Delin Ventures	3
Atlantic Labs	2
O2h Ventures	2
PortfoLion Capital Partners	2
Accel	2
Bonitás Ventures	2
XTX Ventures	2
Euroventures	2
Mercia Fund Managers	1
Merck Global Health Innovation Fund	1
Daniel Waterhouse	1
Vishal Gulati	1
Christian Dahlen	1
Marton Szoke	1
Texas HALO Fund	1
European Commission	1
Societe Generale Asset Management	1
MassMutual Ventures	1
The Vascular Group	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

venture capital

Investment focus

Software, Biotechnology, Information Technology
Seed, Series A, Series B
Hungary, South Korea, United States

Portfolio highlights

Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.

We are partnering with remarkable entrepreneurs and scientists on the mission of our lives: elevating humanity.

Investment focus

Software, Information Technology, Biotechnology
Seed, Series A, Series B
United Kingdom, Hungary, United States

Portfolio highlights

Umedeor — uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access toregulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams
Turbine — Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutictargets or indications, untangling the complexity of cancer.
Ori Biotech — An innovator in Cell and Gene Therapy with a proprietary, flexible manufacturing platform to enable widespread access to lifesaving treatments

Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.

Investment focus

Health Care, Software, Information Technology
Seed, Pre-Seed, Series A
Germany, Switzerland, United States

Portfolio highlights

Embea — Embea takes Embedded Insurance to Life & Health. Our easy-to-understand plans protect families against the most severe life risks of critical illnesses, accidents, and death. Companies of every size embed our simple and transparent insurance products into their apps and services. Embea removes complexity, paperwork, and pushy sales from theworld of life insurance. Our vision is a world where fair and affordable insurance is accessible to everyone.
Purpose Green — Purpose Green operates as a climatetech company.
150 Minuten — Das Startup 150Minuten aus Berlin möchte Menschen aller Alters- und Fitnessklassen für mehr Sport und Bewegung begeistern. Wir bieten ein modernes, interaktives Online-Kursangebot, an dem jede*r (direkt und live) von Zuhause aus teilnehmen kann.

Focused on seeding early stage biotech therapeutics and related AI opportunities. The fund will invest in companies qualifying under EIS and covering novel...

Investment focus

Biotechnology, Health Care, Pharmaceutical
Seed, Series A, Pre-Seed
United Kingdom, Hungary

Portfolio highlights

Kuano — Kuano provides innovative quantum and AI solutions for drug discovery and design. It offers a discovery platform that combines target quantum mapping and AI-led chemistry to enable the faster development of better drug candidates.
PharmEnable — At PharmEnable Therapeutics we access the inaccessible. We are re-imagining small molecule therapeutics through AI.
Pencil Biosciences — Next Generation Genome Editing Tool

Portfolion is a CEE-focused multi-stage investor with a flexible fund structure that allows it to back companies from or before 1st client until the end of their journey. The fund manager has backed some of the CEE region’s most successful companies including SEON, Novakid, Tresorit, Packhelp, and Starschema.

Investment focus

Software, Information Technology, Big Data
Series A, Seed, Series B
Hungary, Poland, Switzerland

Portfolio highlights

deskbird — Most intuitive and people-centric - deskbird's hybrid workplace solution that employees will love. For all flexibe companies, from startup to corporate.
Mindgram — Mindgram is a science-based platform and mobile app for complete mental wellness.
Commsignia — Commsignia specializes in the research and development, manufacturing and distribution of cooperative intelligent transportation systems. Its product line includes a V2X Communication Software Stack and Commsignia’s own security stack implementation, Hybrid V2X/ADAS Safety Applications, a V2X Simulator, On-Board Units (OBU) and Roadside Units(RSU).The company was founded in 2012 and is headquartered in Santa Clara, California.

First partner to exceptional teams everywhere

Investment focus

Software, SaaS, Information Technology
Series A, Series B, Series C
United States, India, United Kingdom

Portfolio highlights

Wonder — Introducing a new kind of home dining experience. Currently available in areas of New Jersey.
Coast — Coast is the simple, all-in-one fleet and fuel card that helps businesses easily pay for and track vehicle expenses. It's quick to set up, easy-to-use, and full of rewards.
Imperia — We provide to our clients tools for managing and optimizing their processes in the area of operations through an innovative, advanced and user-friendly software solution. Analytics Demand Planning (ADP) is a complete solution to support the demand forecasting process, based on two key pillars: 1. Easy-to-use: the solution is fully integrated inExcel, providing great ease of use and minimum implementation times. “If you know how to use Excel, you know how to use ADP”. 2. Collaborative planning: the tool is developed under a collaborative environment in which all members of the organization can be involved in the process, improving the decision-making process.Furthermore, it has great computing power based on statistical models and a wide range of advanced functionalities that add extra value to the product. Such as reference segmentation, intelligent cleaning of historical data series and integrated dashboards for sales and forecast analytics.

Bonitás is more than an investor. Our team helps the brave founders to pursue their dreams and build extraordinary companies. We push because we respect. Partnering with Bonitás, founders can benefit from our unmatched network and gain experience in management support. Bonitás is proud that our backed companies also propel great causes.

Investment focus

Information Technology, Education, Software
Seed, Series A
Hungary

Portfolio highlights

Livlia — As Hungary’s first hybrid real estate service, portal, and ecosystem, Livlia’s goal is to revolutionize the Hungarian and the regional real estate market with their automatized working methods, modern solutions and professional real estate experts. The platform is launching today with the aim of digitalising and revolutionizing and the entire realestate industry.Ads optimization, developed price strategy, pre-identified customers, all of which can be traced on the platform which is complemented by a dedicated real estate expert. As a result of their modern and digitalised solutions and working methods, they thrive working for one of the most competitive success fees (1,5%) within the Hungarian real estate industry offering more, for less.
MITE-CHEM KFT. — Manufacture of pesticides and other agrochemical products
Gremon Systems — Digitalize your production with Gremon: discover the highest agricultural IT inventions in crop production, monitoring and evaluation of data. Be the first!

XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm.XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance those businesses. We are geographyand industry agnostic.

Investment focus

Artificial Intelligence, Machine Learning, Software
Series A, Seed, Funding Round
United States, United Kingdom, Israel

Portfolio highlights

Graide — Give more feedback, faster than ever. Deliver assignments and get immediate insights into student performance. Use artificial intelligence to help you grade.
Swapp — Real estate developers, architects and engineers use Swapp to design buildings in a smart, flexible and efficient process.
BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.

Budapest-based Euroventures is one of the longest-established and leading independent private equity and venture capital firms in Central Europe, with a proven ability to achieve international exits over two decades in a fast-changing environment. It has advised or is advising five investment programmes totalling over €180m since 1989, with a focuson funding INNOVATION and GROWTH in Hungary and Central Europe. The investors in Euroventures funds have been international institutional Investors. Euroventures' nearly 50 current and former portfolio companies illustrate the commitment to provide steady support through the cycles of the regional and global economy. Its professional team members have many decades of private equity / venture capital experience between them. Recent investments have targeted growing businesses with innovative technologies in the fields of medtech, big data, security, and IoT among others. Euroventures has had an outstanding track record in supporting its portfolio companies entering global markets. As a result, it has delivered highly successful exits, including IPOs (Vienna, NASDAQ, NYSE) and several dozens of trade sales to international corporations. Euroventures is a founding member of the Hungarian Venture Capital Association and complies with the conduct, governing principles and valuation/reporting guidelines of Invest Europe.

Investment focus

Software, Information Technology, E-Commerce
Series A, Funding Round, Seed
Hungary, United Kingdom, United States

Portfolio highlights

Antavo Enterprise Loyalty Cloud — Antavo Loyalty Cloud is the most powerful loyalty program technology on the market. Our scalable, pure-play tech integrates easily thanks to robust APIs.
Daytrip — Get to your next destination. Discover beautiful places that would otherwise remain hidden.
Prefixbox — Prefixbox makes eCommerce search easy. Easy to integrate search modules increase conversion rates and online revenue within weeks.

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Investment focus

Software, Health Care, Biotechnology
Seed, Funding Round, Series A
United Kingdom, United States, Hungary

Portfolio highlights

Kuano — Kuano provides innovative quantum and AI solutions for drug discovery and design. It offers a discovery platform that combines target quantum mapping and AI-led chemistry to enable the faster development of better drug candidates.
MGISS — Independently advising on the smarter use of Geospatial data, technology and the digital transformation of field operations.
Workbuzz — Give your Everyday Heroes a voice with employee engagement surveys. Our flexible and simple survey platform reaches all employees, wherever they are. Book a demo now!

Merck Global Health Innovation Fund (MGHIF) is a growth investor partnering with innovative digital health and data science companies that facilitate and optimize biopharmaceutical operations with the goal of improving patient care.

Investment focus

Health Care, Biotechnology, Medical
Series B, Funding Round, Series A
United States, Canada, Mexico

Portfolio highlights

Culmination Bio — Culmination Bio is a startup that is developing a disease-independent patient data intelligence platform.
AeroSafe Global — AeroSafe Global delivers cold chain solutions to the biopharma industry with zero temperature excursions for every patient, every product, every time.
Octave — Octave Bioscience is an early-stage molecular diagnostics company focused on neurodegenerative diseases and conditions. The company was co-founded by Melinda Thomas and William Hagstrom in 2013. Octave Bioscience is headquartered in Menlo Park, California, United States.

Daniel joined Balderton as a General Partner in 2013 and he currently sits on the boards of Revolut, ROLI, Lovecrafts, TrademarkNow, Tictail, Thread, and Workable and also works with Instabridge and Curious.AI.Prior to Balderton, Daniel spent 5 years as a partner at Wellington Partners and invested in a number of fast-growing companiesincluding EyeEm, Hailo, YPlan, Bookatable (also a Balderton portfolio company, sold to Michelin), SumAll, Readmill (sold to Dropbox) and Qype (sold to Yelp).Before Wellington, Daniel was a sector partner at 3i where he worked on all of their venture and private equity investments in the internet sector in North America and Europe.And before that, he was at Yahoo! for six years from 1999, covering strategic development and M&A across the European region. He has a PhD and MA in applied mathematics from Oxford University and a Chartered Diploma in Accounting and Finance.

Investment focus

Software, E-Commerce, Mobile
Series A, Series B, Seed
United Kingdom, Germany, United States

Portfolio highlights

Mapfit — Mapfit was sunset in October 2018. Please see these 16 Google Places API alternatives.
Unaric — Our mission is to help Salesforce customers maximise their investment on the Salesforce platform through an integrated suite of applications. Explore our application suites across Revenue Operations, Service Operations and System Administration.
Kama — Kama offers sexual wellness practices that improve how you experience love, sex, and intimacy. Available on the iOS App Store.

Vishal Gulati: Vishal serves as a venture partner specialising in digital health at DFJ Esprit, Europe's leading Silicon Valley style venture capital firm with over $1b under management. Since 2012, Vishal has been Europe’s leading promoter of investment into the emerging digital health sector and chairman of Digital Health Forum, whichsupports the best in class digital health companies to grow into global enterprises. Vishal serves on several boards including Horizon Discovery Group PLC (Cambridge, UK), a gene editing company; Fluidics Analytics (Cambridge, UK), a next gen protein discovery engine, Frameshift a healthcare information flow platform (London, UK) and EcoEos (San Francisco, USA), a consumer genomics business. His previous investments include Napo Pharmaceuticals, Glenmark, Renovo and Phagenesis.

Investment focus

Biotechnology, Biopharma, Life Science
Seed, Series A, Series B
United Kingdom, Hungary

Portfolio highlights

Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
evonetix — Spearheading a radical new approach to gene synthesis to improve access to high-quality, gene-length DNA. Redefine possible.
Turbine — Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutictargets or indications, untangling the complexity of cancer.

Christian Dahlen is a business angel. He provides expert capital and venture advice to B2B SW startups in Silicon Valley and in Germany. He is a member of the Band of Angels, Silicon Valley's oldest seed funding organization. Christian was a VP at SAP and held various roles in business strategy and operations. Prior to SAP, he was theGeneral Manager for the Internet and phone business of Kabel Deutschland (KDG), Germany's largest cable operator. He joined KDG from Excite@Home, and before that was with McKinsey & Co.

Investment focus

Software, Artificial Intelligence, Analytics
Seed, Pre-Seed, Funding Round
United States, Germany, France

Portfolio highlights

clous — Hybrid automated mechanical engineering
Deltia — We use computer vision and AI analytics to provide insights into manual assembly processes - our platform supports process engineers in driving productivity and quality of assembly processes
comstruct — Zeit und Geld sparen durch digitale Lieferscheine statt Papierscheine. Profitieren Sie von den Vorteilen strukturierter Produktgruppendaten!

An entrepreneur and investor with a business background and solid technical experience. Founded several startups, the latest being Indextools, a software company specializing in enterprise on-demand web analytics software. In April 2008 Indextools got acquired by Yahoo! Inc. At the time of the acquisition, Indextools was recognized as one of thetop five web analytics vendors world-wide by Forrester / Jupiter Research. Mr. Szőke served at Yahoo for three years to lead integration efforts and to realign Indextools’ business model.

Investment focus

Information Technology, Software, EdTech
Series A, Pre-Seed, Series B
Hungary, Switzerland, Czech Republic

Portfolio highlights

Omixon — Omixon is a biotechnology company that specializes in high-resolution HLA genotyping.
Ydistri — Digital tool for slow moving inventory problem
Logiscool — International franchise network teaching kids programming

Early Stage Venture Investments

Investment focus

Health Care, Medical Device, Software
Seed, Convertible Note, Series A
United States, Canada, Hungary

Portfolio highlights

Flourish Collective — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.

The official website of the European Commission, providing access to information about its political priorities, policies and services

Investment focus

Software, Health Care, Biotechnology
Grant, Seed, Pre-Seed
Spain, France, Germany

Portfolio highlights

SIMTEL Team — SIMTEL Team is a greenttech company that specializes in construction and maintenance of photovoltaic power plants.
SolarSpring — SolarSpring GmbH develops and produces pure water systems from clean materials. Thermal energy, photovoltaic (PV) energy, and energy gained from waste heat is used to promote water purification technologies such as membrane distillation and UV disinfection. The company's know how focuses on water purification systems operating based ondiscontinuous or minor energy sources.
Chemring Group — Chemring Group is a defense technology company engaged in the development and manufacture of countermeasures, sensors, and energetic systems for the aerospace, defense, and security markets. Its segments are countermeasures, sensors and energetic systems. The group has a product range including conventional flares, flares, special material decoys,chaff, and naval countermeasures. The group is also a contract research and development supplier. The company has four business units in North America supplying mainly to the US Department of Defense and its prime contractors seven businesses in Europe, supplying NATO and non-NATO customers and one business in Asia Pacific.

SGAM AI is a leading institutional player in Alternative Investment Management. SGAM AI successfully mixes the cultures of asset management and capital markets. They are client driven and institutional, like an asset manager. Their approach of each market is entrepreneurial and financial, like an investment bank. They offer the widest coverage ofAlternative Investment classes. Their size and profitability allow long term investments and credibility. They have the ability to offer solutions, not only products. SG Group's strengths are brought to the Alternative Investment's industry. They benefit from SG Group's long term commitment in Alternative Investments. They use the processes ans resources of SGAM Group (rated M2 by Fitch).

Investment focus

Biotechnology, Software, Health Care
Series B, Funding Round, Series A
France, United States, Germany

Portfolio highlights

Augure — Augure by Launchmetrics' software and social data help brands and agencies to bridge the gap between traditional PR and Influencer Marketing. Every day, more than 1,000 Communication, PR, and Public Affairs teams use the Publisher platform to engage relevant influencers, manage their campaigns, improve efficiency and increase their presence inthe media and on social networks.The Augure by Launchmetrics' data services team compliments the Publisher software as the people behind the technology, offering consulting services that help clients to make sense of the data and apply it to their Influencer Marketing strategies.Founded in 2002 in Paris, Augure operates in Europe and Latin America. Its clients include Orange, Thales, AG Insurance, Pierre & Vacances, Château de Versailles, Amalthea, Hill+Knowlton and many others that span across the corporate sector.
Force-A — FORCE-A designs, produces, and sells optical sensors for the assessment of physiological and health status of crops. It offers crop sensors for nondestructive assessment of leaf polyphenolics. The company also provides multiparameter noncontact sensors-based on leaves or fruits, and berries autofluorescence measurements. Its multiparameternoncontact sensor provides inputs for decision support systems for a range of crops, including fertilisation needs, weed infestation, crop diseases, and crop yield and quality forecast. The company was founded in 2004 and is based in Orsay, France.
METRIXWARE — Metrixware has, since 1995, been providing software maintenance & quality management solutions to CIOs and IT professionals through its System Code range of application management tools. The company provides global organizations with information, indicators and diagnostic to streamline decision making and implement best practice and compliancestandards.

MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.

Investment focus

Software, Financial Services, Information Technology
Series A, Series B, Seed
United States, India, Singapore

Portfolio highlights

XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
Qoala — Asuransi online yang siap melindungi kamu dan orang tersayang, di mana aja, kapan aja. Premi murah, proses klaim mudah, dan 100% digital!
Scrut Automation — Scrut Automation makes ISO 27001, SOC 2, GDPR and PCI DSS compliance easy, with 70% less Manual effort

The Vascular Group is a medical practice company that delivers art diagnostic and therapeutic procedures.

Investment focus

Medical, Health Care, Biotechnology
Series A
Hungary

Portfolio highlights

VRG Therapeutics — VRG Therapeutics is a biotechnology company that focuses on miniprotein-based medications and cellular and gene therapy (CGT) technologies.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate